With the aim of "making every Chinese diabetic have a blood glucose meter", in 2002, Sinocare was founded in Changsha, China. From the outset, Sinocare has been dedicating to providing innovative, high-quality products and services to people with diabetes and other chronic diseases to improve their quality of life.

In 2016, Sinocare acquired Nipro Diagnostic Inc. (now renamed as Trividia Health Inc.) and PTS Diagnostics Inc., marking our entry into the global elite circle of the blood glucose meter industry. With 7 major R&D centers and 8 production bases across the globe. Sinocare has established a dominant presence in the global blood glucose monitoring market, ranking No.1 in China and No.4 worldwide. Each step we take is firmly in line with our vision of becoming “the Leading Diabetes Digital Management Expert in the World”.

Sinocare has established a dominant presence in the global blood glucose monitoring market. Today, Sinocare is proud to serve over 25 million users worldwide, with a business footprint in 135 countries and regions. Our products and technologies are at the forefront of the industry, earning us a string of prestigious awards both on a national and industry scale, including the “National Science and Technology Progress Award”, “National Technology Innovation Demonstration Enterprise”, “National Intellectual Property Advantage Enterprise”, among others.

At Sinocare, our core value is rooted in "Caring for Love." From the outset, Sinocare has been focusing on advancing the diabetes healthcare cause and a dedication to innovations in biosensor technology.

Sinocare’s products, known for being “precise, simple, and affordable”, have garnered widespread praise from consumers across China. Our current portfolio includes blood glucose meters, continuous glucose monitoring system, along with dual-function and “three-in-one” monitoring systems, mobile blood glucose meters, and intelligent blood glucose monitoring systems. We also aim to build a digital management model for diabetes and associated chronic diseases, integrating "biosensors, the Internet of Things (IoT), smart healthcare, and guidance for healthy lifestyles", offering more innovative and systematic smart medical solutions in the prevention and management of chronic diseases.